Meta-Analyses Support Previous and Novel Autism Candidate Genes: Outcomes of an Unexplored Brazilian Cohort.


Journal

Autism research : official journal of the International Society for Autism Research
ISSN: 1939-3806
Titre abrégé: Autism Res
Pays: United States
ID NLM: 101461858

Informations de publication

Date de publication:
02 2020
Historique:
received: 31 05 2019
revised: 23 09 2019
accepted: 14 10 2019
pubmed: 7 11 2019
medline: 18 11 2020
entrez: 8 11 2019
Statut: ppublish

Résumé

Large genomic databases of neurodevelopmental disorders (NDD) are helpful resources of genomic variations in complex and heterogeneous conditions, as Autism Spectrum Disorder (ASD). We evaluated the role of rare copy number variations (CNVs) and exonic de novo variants, in a molecularly unexplored Brazilian cohort of 30 ASD trios (n = 90), by performing a meta-analysis of our findings in more than 20,000 patients from NDD cohorts. We identified three pathogenic CNVs: two duplications on 1q21 and 17p13, and one deletion on 4q35. CNVs meta-analysis (n = 8,688 cases and n = 3,591 controls) confirmed 1q21 relevance by identifying duplications in other 16 ASD patients. Exome analysis led the identification of seven de novo variants in ASD genes (SFARI list): three loss-of-function pathogenic variants in CUL3, CACNA1H, and SHANK3; one missense pathogenic variant in KCNB1; and three deleterious missense variants in ATP10A, ANKS1B, and DOCK1. From the remaining 12 de novo variants in non-previous ASD genes, we prioritized PRPF8 and RBM14. Meta-analysis (n = 13,754 probands; n = 2,299 controls) identified six and two additional patients with validated de novo variants in PRPF8 and RBM14, respectively. By comparing the de novo variants with a previously established mutational rate model, PRPF8 showed nominal significance before multiple test correction (P = 0.039, P-value adjusted = 0.079, binomial test), suggesting its relevance to ASD. Approximately 60% of our patients presented comorbidities, and the diagnostic yield was estimated in 23% (7/30: three pathogenic CNVs and four pathogenic de novo variants). Our uncharacterized Brazilian cohort with tetra-hybrid ethnic composition was a valuable resource to validate and identify possible novel candidate loci. Autism Res 2020, 13: 199-206. © 2019 International Society for Autism Research, Wiley Periodicals, Inc. LAY SUMMARY: We believed that to study an unexplored autistic population, such as the Brazilian, could help to find novel genes for autism. In order to test this idea, with our limited budget, we compared candidate genes obtained from genomic analyses of 30 children and their parents, with those of more than 20,000 individuals from international studies. Happily, we identified a genetic cause in 23% of our patients and suggest a possible novel candidate gene for autism (PRPF8).

Identifiants

pubmed: 31696658
doi: 10.1002/aur.2238
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

199-206

Subventions

Organisme : Conselho Nacional de Desenvolvimento Científico e Tecnológico
ID : 466651/2014-7
Pays : International
Organisme : Fundação de Amparo à Pesquisa do Estado de São Paulo
ID : 2013/08028-1
Pays : International
Organisme : Fundação de Amparo à Pesquisa do Estado de São Paulo
ID : 2017/05824-2
Pays : International

Informations de copyright

© 2019 International Society for Autism Research, Wiley Periodicals, Inc.

Références

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-V (5th ed.). Arlington, VA: American Psychiatric Publishing.
Battaglia, A., Doccini, V., Bernardini, L., Novelli, A., Loddo, S., Capalbo, A., … Carey, J. C. (2013). Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. European Journal of Paediatric Neurology, 17(6), 589-599. http://doi.org/10.1016/j.ejpn.2013.04.010
Bourgeron, T. (2015). From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nature Reviews Neuroscience, 16(9), 551-563. http://doi.org/10.1038/nrn3992
Bruno, D. L., Anderlid, B., Lindstrand, A., Van Ravenswaaij-arts, C., Ganesamoorthy, D., Lundin, J., … Schoumans, J. (2010). Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes. Journal of Medical Genetics, 47, 299-312. http://doi.org/10.1136/jmg.2009.069906
Calhoun, J. D., Vanoye, C. G., Kok, F., George, A. L., & Kearney, J. A. (2017). Characterization of a KCNB1 variant associated with autism, intellectual disability, and epilepsy. Neurology Genetics, 3(6), e198. http://doi.org/10.1212/NXG.0000000000000198
Capra, V., Mirabelli-badenier, M., Stagnaro, M., Rossi, A., Tassano, E., Gimelli, S., & Gimelli, G. (2012). Identification of a rare 17p13. 3 duplication including the BHLHA9 and YWHAE genes in a family with developmental delay and behavioural problems. BMC Medical Genetics, 13(1), 93. http://doi.org/10.1186/1471-2350-13-93
Casanova, E. L., Gerstner, Z., Sharp, J. L., & Casanova, M. F. (2018). Widespread genotype-phenotype correlations in intellectual disability. Frontiers in Psychiatry, 9(1), 535. http://doi.org/10.3389/fpsyt.2018.00535
Chien, W. H., Gau, S. F., Wu, Y. Y., Huang, Y. S., Fang, J. S., Chen, Y. J., … Chen, C. H. (2010). Identification and molecular characterization of two novel chromosomal deletions associated with autism. Clinical Genetics, 78(5), 449-456. http://doi.org/10.1111/j.1399-0004.2010.01395.x
Coe, B. P., Stessman, H. A. F., Sulovari, A., Geisheker, M. R., Bakken, T. E., Lake, A. M., … Eichler, E. E. (2019). Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity. Nature Genetics, 51(1), 106-116. https://doi.org/10.1038/s41588-018-0288-4
Cristino, A. S., Williams, S. M., Hawi, Z., An, J. Y., Bellgrove, M. A., Schwartz, C. E., … Claudianos, C. (2014). Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system. Molecular Psychiatry, 19(3), 294-301. https://doi.org/10.1038/mp.2013.16
Curry, C. J., Rosenfeld, J. A., Grant, E., Gripp, K. W., Anderson, C., Aylsworth, A. S., … Dybose, G. (2013). The duplication 17p13.3 phenotype: Analysis of 21 families delineates developmental, behavioral and brain abnormalities, and rare variant phenotypes. American Journal of Medical Genetics, Part A, 161A(8), 1833-1852. http://doi.org/10.1002/ajmg.a.35996.The
de Kovel, C. G. F., Syrbe, S., Brilstra, E. H., Verbeek, N., Kerr, B., Dubbs, H., … Koeleman, B. P. C. (2017). Neurodevelopmental disorders caused by de novo variants in kcnb1 genotypes and phenotypes. JAMA Neurology, 74(10), 1228-1236. http://doi.org/10.1001/jamaneurol.2017.1714
De Rubeis, S., He, X., Goldberg, A. P., Poultney, C. S., & Samocha, K. (2014). Synaptic, transcriptional, and chromatin genes disrupted in autism A. Nature, 515(7526), 209-215. http://doi.org/10.14440/jbm.2015.54.A
Fogo, M. S., & Griesi-oliveira, K. (2018). Gene expression study in neural cells derived from induced pluripotent stem cells of individuals with Autism Spectrum Disorder. Brazil: Universidade de São Paulo Retrieved from http://www.teses.usp.br/teses/disponiveis/41/41131/tde-13122018-083852
Grainger, R. J., & Beggs, J. D. (2005). Prp8 protein: At the heart of the spliceosome. RNA, 11, 533-557. http://doi.org/10.1261/rna.2220705.RNA
Iossifov, I., O'roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., … Wigler, M. (2014). The contribution of de novo coding mutations to autism spectrum disorder. Nature, 13(515), 216-221. http://doi.org/10.15154/1149697
Kushima, I., Aleksic, B., Nakatochi, M., Shimamura, T., Okada, T., Uno, Y., … Ozaki, N. (2018). Comparative analyses of copy-number variation in autism spectrum disorder and schizophrenia reveal etiological overlap and biological insights. Cell Reports, 24(11), 2838-2856. https://doi.org/10.1016/j.celrep.2018.08.022
Lelieveld, S. H., Reijnders, M. R. F., Pfundt, R., Yntema, H. G., Kamsteeg, E. J., De Vries, P., … Gilissen, C. (2016). Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability. Nature Neuroscience, 19(9), 1194-1196. http://doi.org/10.1038/nn.4352
Maciejewski, J. P., & Padgett, R. A. (2012). Defects in spliceosomal machinery: A new pathway of leukemogenesis. British Journal of Haematology, 158(2), 165-173. http://doi.org/10.1111/j.1365-2141.2012.09158.x
Marini, C., Romoli, M., Parrini, E., Costa, C., Mei, D., Mari, F., … Vita, D. D. (2017). Clinical features and outcome of 6 new patients carrying de novo KCNB1 gene mutations. Neurology Genetics, 3(6), 1-9. http://doi.org/10.1212/NXG.0000000000000206
Marshall, C. R., Noor, A., Vincent, J. B., Lionel, A. C., Feuk, L., Skaug, J., … Scherer, S. W. (2008). Structural Variation of Chromosomes in Autism Spectrum Disorder. American Journal of Human Genetics, 82(2), 477-488. http://doi.org/10.1016/j.ajhg.2007.12.009
Mefford, H., Sharp, A., Baker, C., Itsara, A., Jiang, K., Buysse, K., … Eichler, E. (2008). Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. The New England Journal of Medicine, 359(16), 1685-1699. http://doi.org/10.1056/NEJMoa0805384
Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., … Ledbetter, D. H. (2010). Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics, 86(5), 749-764. http://doi.org/10.1016/j.ajhg.2010.04.006
Miura, K., Kumagai, T., Matsumoto, A., Iriyama, K., Watanabe, K., Goto, K., & Arahata, K. (1998). Two cases of chromosome 4q35-linked early onset facioscapulohumeral muscular dystrophy with mental retardation and epilepsy. Neuropediatrics, 29, 239-241. http://doi.org/10.1055/s-2007-973568
Naslavsky, M. S., Yamamoto, G. L., De Almeida, T. F., Ezquina, S. A. M., Sunaga, D. Y., Pho, N., … Zatz, M. (2017). Exomic variants of an elderly cohort of Brazilians in the ABraOM database Michel. Human Mutation, 38(7), 751-763. http://doi.org/10.1002/humu.23220
Neale, B., Kou, Y., Liu, L., & Ma'ayan, A. (2012). Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature, 485(7397), 242-245. http://doi.org/10.1038/nature11011
Parrini, E., Marini, C., Mei, D., Galuppi, A., Cellini, E., Chiti, L., … Montomoli, M. (2016). Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes. Human Mutation, 38(2), 216-225. http://doi.org/10.1002/humu.23149
Pickard, B. S., Hollox, E. J., Malloy, M. P., Porteous, D. J., Blackwood, D. H. R., Armour, J. A. L., & Muir, W. J. (2004). A 4q35.2 subtelomeric deletion identified in a screen of patients with co-morbid psychiatric illness and mental retardation. BMC Medical Genetics, 7, 1-7. http://doi.org/10.1186/1471-2350-5-21
Pinto, D., Delaby, E., Merico, D., Barbosa, M., Merikangas, A., Klei, L., … Scherer, S. W. (2014). Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. American Journal of Human Genetics, 94(5), 677-694. http://doi.org/10.1016/j.ajhg.2014.03.018
Prasad, A., Merico, D., Thiruvahindrapuram, B., Wei, J., Lionel, A. C., Sato, D., … Scherer, S. W. (2012). A discovery resource of rare copy number variations in individuals with autism spectrum disorder. G3: Genes, Genomes, Genetics, 2(12), 1665-1685. http://doi.org/10.1534/g3.112.004689
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., & Grody, W. W. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the association for molecular pathology. Genetics in Medicine, 17(5), 405-424. http://doi.org/10.1038/gim.2015.30
Samocha, K. E., Robinson, E. B., Sanders, S. J., Sabo, A., Mcgrath, L. M., Kosmicki, J. A., … Daniel, G. (2014). A framework for the interpretation of de novo mutation in human disease. Nature Genetics, 46(9), 944-950. http://doi.org/10.1038/ng.3050.A
Sánchez-Sánchez, S., Magdalon, J., Griesi-Oliveira, K., Yamamoto, G., Santacruz-perez, C., Fogo, M., … Sertié, A. (2018). Rare RELN variants affect Reelin-DAB1 signal transduction in autism spectrum disorder. Human Mutation, 39(10), 1372-1383. http://doi.org/10.1002/humu.23584
Sanders, S. J., He, X., Willsey, A. J., Mandell, J. D., Moreno-De-Luca, D., Poultney, C. S., … State, M. W. (2015). Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron, 87(6), 1215-1233. https://doi.org/10.1016/j.neuron.2015.09.016
Schumacher, F., Siew, K., Zhang, J., Johnson, C., Wood, N., Cleary, S. E., … Kurz, T. (2015). Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia. EMBO Molecular Medicine, 7(10), 1285-1306. http://doi.org/10.15252/emmm.201505444
Shen, A. Y., Dies, K. A., Holm, I., Bridgemohan, C., Sobeih, M. M., Caronna, E., … Miller, D. T. (2010). Clinical genetic testing for patients with autism spectrum disorders. Pediatrics, 125(4), 727-735.
Srivastava, M., Fleming, P. J., Pollard, H. B., & Burns, A. L. (1989). Cloning and sequencing of the human nucleolin cDNA. FEBS Letters, 250(1), 99-105. http://doi.org/https://doi.org/10.1016/0014-5793(89)80692-1
Tammimies, K., Marshall, C. R., Walker, S., Kaur, G., Thiruvahindrapuram, B., Lionel, A. C., … Fernandez, B. A. (2015). Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children with autism spectrum disorder. JAMA, 314(9), 895-903. http://doi.org/10.1001/jama.2015.10078
Turner, T. N., Coe, B. P., Dickel, D. E., Pennacchio, L. A., Darnell, R. B., Eichler, E. E., … Darnell, R. B. (2017). Genomic patterns of de novo mutation in simplex autism. Cell, 171(3), 710-722. http://doi.org/10.1016/j.cell.2017.08.047
Yuen, R. K., Merico, D., Bookman, M., Howe, J. L., Thiruvahindrapuram, B., Patel, R. V., … Szatmari, P. (2017). Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nature Neuroscience, 20, 602-611. http://doi.org/10.1038/nn.4524
Zhou, L., Ye, S., Yang, H., Zhou, Y.-T., Zhao, Q.-H., Wei-Wen, S., … Long, Y. S. (2017). A novel role of fragile X mental retardation protein in pre-mRNA alternative splicing through RNA-binding protein 14. Neuroscience, 349, 64-75. http://doi.org/10.1016/j.neuroscience.2017.02.044

Auteurs

Eduarda Morgana da Silva Montenegro (EM)

Departamento de Genética e Biologia Evolutiva, Centro de Estudos do Genoma Humano e Células-tronco, Instituto de Biociências, Universidade de São Paulo, São Paulo, SP, Brazil.

Claudia Samogy Costa (CS)

Departamento de Genética e Biologia Evolutiva, Centro de Estudos do Genoma Humano e Células-tronco, Instituto de Biociências, Universidade de São Paulo, São Paulo, SP, Brazil.

Gabriele Campos (G)

Departamento de Genética e Biologia Evolutiva, Centro de Estudos do Genoma Humano e Células-tronco, Instituto de Biociências, Universidade de São Paulo, São Paulo, SP, Brazil.

Marília Scliar (M)

Departamento de Genética e Biologia Evolutiva, Centro de Estudos do Genoma Humano e Células-tronco, Instituto de Biociências, Universidade de São Paulo, São Paulo, SP, Brazil.

Tatiana Ferreira de Almeida (TF)

Departamento de Genética e Biologia Evolutiva, Centro de Estudos do Genoma Humano e Células-tronco, Instituto de Biociências, Universidade de São Paulo, São Paulo, SP, Brazil.

Elaine Cristina Zachi (EC)

Departamento de Genética e Biologia Evolutiva, Centro de Estudos do Genoma Humano e Células-tronco, Instituto de Biociências, Universidade de São Paulo, São Paulo, SP, Brazil.

Isabela Maya Wahys Silva (IMW)

Departamento de Genética e Biologia Evolutiva, Centro de Estudos do Genoma Humano e Células-tronco, Instituto de Biociências, Universidade de São Paulo, São Paulo, SP, Brazil.

Ada J S Chan (AJS)

The Centre for Applied Genomics, Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Mehdi Zarrei (M)

Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Naila C V Lourenço (NCV)

Departamento de Genética e Biologia Evolutiva, Centro de Estudos do Genoma Humano e Células-tronco, Instituto de Biociências, Universidade de São Paulo, São Paulo, SP, Brazil.

Guilherme Lopes Yamamoto (GL)

Departamento de Genética e Biologia Evolutiva, Centro de Estudos do Genoma Humano e Células-tronco, Instituto de Biociências, Universidade de São Paulo, São Paulo, SP, Brazil.

Stephen Scherer (S)

The Centre for Applied Genomics, Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Maria Rita Passos-Bueno (MR)

Departamento de Genética e Biologia Evolutiva, Centro de Estudos do Genoma Humano e Células-tronco, Instituto de Biociências, Universidade de São Paulo, São Paulo, SP, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH